BioSpace News Archive

Thermo Fisher Scientific has developed a new Total Residual Oxidant (TRO) analyzer to address the needs of the wastewater industry, which calls for a robust, dependable instrument capable of reliably measuring low ppb chlorine concentrations in effluent and treated wastewater in line with stringent regulatory requirements.

Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces that the Company has received Investigational Device Exemption (IDE) for the LiquiBand® Fix8™ device in the US.

Malin Corporation plc. (Euronext Growth Dublin:MLC) (“Malin”), a company investing in highly innovative life sciences companies, is pleased to note that Poseida Therapeutics Inc. (“Poseida”), one of Malin’s Priority Assets, has announced the US Food and Drug Administration (“FDA”) has granted orphan drug designation to P-BCMA-101 for the treatment of relapsed and/or refractory multiple myeloma.

Bone Sci Bio introduces PeptOss, a novel solution for bone treatment. The new product promotes formation and repair of bone tissue and enables controlled delivery of drugs, such as antibiotics or chemotherapy, directly to the bone, for various orthopedic and dental applications.

ADC Biotechnology (ADC Bio), together with Maven Capital Partners and Bioscience Managers, is to host a webinar through ADC Review entitled ‘Investing for the future: unlocking advanced ADC manufacturing innovation” at 16:00 UK GMT time on 15 May 2019.

The Health Coalition on Liability and Access announced its support for the Good Samaritan Health Professionals Act, introduced as S. 1350 by Senator Bill Cassidy, in order to better facilitate access to care when it is needed most.

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced the launch of two additional HANAROSTENT® self-expanding metal stents (SEMS) at Digestive Disease Week (DDW) 2019.

VITAS® Healthcare, the nation’s leading provider of end-of-life care, announces the grand opening of the VITAS Healthcare Inpatient Unit (IPU) at Good Samaritan Medical Center.

When a large national employer removed cost sharing for primary care visits, medical utilization fell, as did monthly costs, driven mostly by reduced emergency department (ED) visits.